ANIK
Anika Therapeutics, Inc.
Latest Form 4:Purchase$21KbyFischetti Gary P (Director) · filed Aug 5, 2026
Anika Therapeutics, Inc. (ANIK) has 16 SEC Form 4 filings (35 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 5, 2026.
Insiders have net bought $264K over the trailing 6 months.
- Industry:Medical - Specialties
- CEO:Stephen D. Griffin
- Employees:235
- HQ:Bedford, MA, US
- IPO:1993-05-03
Insider Buying
$264K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$282.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Fischetti Gary PFirst filing | Director | Purchase | 1,000 | $21K | Aug 5 | SEC ↗ |
Fischetti Gary PFirst filing | Director | Purchase | 1,000 | $20K | Aug 5 | SEC ↗ |
HENNEMAN JOHN B IIIFirst filing | Insider | Purchase | 5,000 | $73K | May 4 | SEC ↗ |
Griffin Stephen D.First filing | President and CEO | Purchase | 12,200 | $150K | Apr 30 | SEC ↗ |
Related companies
Anika Therapeutics, Inc. is in the Healthcare sector.